Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-04-30
2008-11-25
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S373000
Reexamination Certificate
active
07456184
ABSTRACT:
A melanocortin receptor-specific compound of the general formula of structure I:where X, R1, R2a, R2b, R3, R4a, R4b, R5aand R5bare as defined in the specification, which compound binds with high affinity to one or more melanocortin receptors and is optionally an agonist, an antagonist, an inverse agonist or an antagonist of an inverse agonist, and may be employed for treatment of one or melanocortin receptor-associated conditions or disorders, and methods for the use of the compounds of the invention.
REFERENCES:
patent: 4148923 (1979-04-01), Giudicelli et al.
patent: 4239763 (1980-12-01), Milavec et al.
patent: 4626549 (1986-12-01), Molloy et al.
patent: 4680289 (1987-07-01), Applezweig
patent: 4711957 (1987-12-01), Lai
patent: 4766125 (1988-08-01), Van Daele et al.
patent: 4937267 (1990-06-01), Holloway et al.
patent: 4943578 (1990-07-01), Naylor et al.
patent: 4968684 (1990-11-01), Van Daele et al.
patent: 4997836 (1991-03-01), Sugihara et al.
patent: 5120713 (1992-06-01), Mugica
patent: 5292726 (1994-03-01), Ashton et al.
patent: 5344830 (1994-09-01), Mills et al.
patent: 5348955 (1994-09-01), Greenlee et al.
patent: 5464788 (1995-11-01), Bock et al.
patent: 5550131 (1996-08-01), Sugihara et al.
patent: 5574031 (1996-11-01), Abramo et al.
patent: 5599809 (1997-02-01), Hickey et al.
patent: 5672602 (1997-09-01), Burkholder et al.
patent: 5736539 (1998-04-01), Graham et al.
patent: 5753445 (1998-05-01), Fillit et al.
patent: 5753653 (1998-05-01), Bender et al.
patent: 5798359 (1998-08-01), Shue et al.
patent: 5804578 (1998-09-01), Chakravarty et al.
patent: 5856326 (1999-01-01), Anthony et al.
patent: 5968938 (1999-10-01), Williams et al.
patent: 6020334 (2000-02-01), Fukushi et al.
patent: 6033656 (2000-03-01), Mikami et al.
patent: 6127424 (2000-10-01), Martin et al.
patent: 6140354 (2000-10-01), Dax et al.
patent: 6162805 (2000-12-01), Hefti
patent: 6191117 (2001-02-01), Kozachuk
patent: 6207665 (2001-03-01), Bauman et al.
patent: 6207699 (2001-03-01), Rothman
patent: 6214831 (2001-04-01), Yokoo et al.
patent: 6294539 (2001-09-01), Lou et al.
patent: 6316470 (2001-11-01), Kover et al.
patent: 6350760 (2002-02-01), Bakshi et al.
patent: 6372747 (2002-04-01), Taveras et al.
patent: 6376509 (2002-04-01), Bakshi et al.
patent: 6410548 (2002-06-01), Nargund et al.
patent: 6432959 (2002-08-01), Cooper et al.
patent: 6458790 (2002-10-01), Palucki et al.
patent: 6469006 (2002-10-01), Blair et al.
patent: 6472398 (2002-10-01), Palucki et al.
patent: 6486165 (2002-11-01), Zhang et al.
patent: 6531476 (2003-03-01), Heymans et al.
patent: 6534503 (2003-03-01), Dines et al.
patent: 6534509 (2003-03-01), Bauman et al.
patent: 6555537 (2003-04-01), Bauman et al.
patent: 6569861 (2003-05-01), Bakthavatchalam et al.
patent: 6579968 (2003-06-01), Blood et al.
patent: 6699873 (2004-03-01), Maguire et al.
patent: 6734175 (2004-05-01), Hadcock et al.
patent: 2001/0018075 (2001-08-01), Shigeyuki et al.
patent: 2001/0047001 (2001-11-01), Varkhedkar et al.
patent: 2002/0004512 (2002-01-01), Bakshi et al.
patent: 2002/0010182 (2002-01-01), Masaaki et al.
patent: 2002/0032238 (2002-03-01), Priepke et al.
patent: 2002/0037837 (2002-03-01), Takada et al.
patent: 2002/0052383 (2002-05-01), Bakthavatchalam et al.
patent: 2002/0065277 (2002-05-01), Hadcock et al.
patent: 2002/0072604 (2002-06-01), Carpino et al.
patent: 2002/0082263 (2002-06-01), Lou et al.
patent: 2002/0107253 (2002-08-01), Koh et al.
patent: 2002/0107255 (2002-08-01), Blimberg et al.
patent: 2002/0128270 (2002-09-01), Neya et al.
patent: 2002/0137664 (2002-09-01), Bakshi et al.
patent: 2002/0143141 (2002-10-01), Chen et al.
patent: 2002/0173512 (2002-11-01), Moltzen et al.
patent: 2002/0177598 (2002-11-01), Bauman et al.
patent: 2002/0183316 (2002-12-01), Pan et al.
patent: 2003/0004162 (2003-01-01), Treadway
patent: 2003/0013721 (2003-01-01), Meghani et al.
patent: 2003/0040520 (2003-02-01), Guzi et al.
patent: 2003/0055247 (2003-03-01), Cosford et al.
patent: 2003/0060473 (2003-03-01), Neya et al.
patent: 2003/0069169 (2003-04-01), Macor et al.
patent: 2003/0083228 (2003-05-01), Carpino et al.
patent: 2003/0083335 (2003-05-01), Hayward
patent: 2003/0092732 (2003-05-01), Yu et al.
patent: 2003/0096827 (2003-05-01), Yu et al.
patent: 2003/0105106 (2003-06-01), Chiang et al.
patent: 2003/0109556 (2003-06-01), Mazur et al.
patent: 2003/0125334 (2003-07-01), Chiang et al.
patent: 2003/0139425 (2003-07-01), Bauman et al.
patent: 2003/0144277 (2003-07-01), DeLucca
patent: 2003/0149019 (2003-08-01), Bremberg et al.
patent: 2003/0158205 (2003-08-01), Baumann et al.
patent: 2003/0158209 (2003-08-01), Dyke et al.
patent: 2003/0166637 (2003-09-01), Lehmann-Lintz et al.
patent: 2003/0181441 (2003-09-01), Mcclure et al.
patent: 2003/0191136 (2003-10-01), Bakthavatchalam et al.
patent: 2003/0195212 (2003-10-01), Lundstedt et al.
patent: 2004/0024211 (2004-02-01), Boyce et al.
patent: 2004/0053933 (2004-03-01), Pontillo et al.
patent: WO 98/10653 (1998-03-01), None
patent: WO 00/05373 (2000-02-01), None
patent: WO 01/21647 (2000-03-01), None
patent: WO 00/40247 (2000-07-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/10842 (2001-02-01), None
patent: WO 01/12176 (2001-02-01), None
patent: WO 01/18210 (2001-03-01), None
patent: WO 01/21634 (2001-03-01), None
patent: WO 01/23392 (2001-04-01), None
patent: WO 01/30343 (2001-05-01), None
patent: WO 02/00259 (2001-06-01), None
patent: WO 01/55106 (2001-08-01), None
patent: WO 01/55107 (2001-08-01), None
patent: WO 01/55109 (2001-08-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/00654 (2002-01-01), None
patent: WO 02/12178 (2002-02-01), None
patent: WO 02/18437 (2002-03-01), None
patent: WO 02/47670 (2002-06-01), None
patent: WO 02/059095 (2002-08-01), None
patent: WO 02/059107 (2002-08-01), None
patent: WO 02/059108 (2002-08-01), None
patent: WO 02/059117 (2002-08-01), None
patent: WO 02/062766 (2002-08-01), None
patent: WO 02/064091 (2002-08-01), None
patent: WO 02/067869 (2002-09-01), None
patent: WO 02/068387 (2002-09-01), None
patent: WO 02/068388 (2002-09-01), None
patent: WO 02/069905 (2002-09-01), None
patent: WO 02/70511 (2002-09-01), None
patent: WO 02/079146 (2002-10-01), None
patent: WO 02/079203 (2002-10-01), None
patent: WO 02/081443 (2002-10-01), None
patent: WO 02/085925 (2002-10-01), None
patent: WO 02/092566 (2002-11-01), None
patent: WO 03/006620 (2003-01-01), None
patent: WO 03/007949 (2003-01-01), None
patent: WO 03/009847 (2003-02-01), None
patent: WO 03/009850 (2003-02-01), None
patent: WO 03/013509 (2003-02-01), None
patent: WO 03/013571 (2003-02-01), None
patent: WO 03/066587 (2003-02-01), None
patent: WO 03/020724 (2003-03-01), None
patent: WO 03/031410 (2003-04-01), None
patent: WO 03/053927 (2003-07-01), None
patent: WO 03/061660 (2003-07-01), None
patent: WO 03/092690 (2003-11-01), None
patent: WO 03/093234 (2003-11-01), None
Adan, Roger A., et al., “Identification of Antagonist for Melanocortin MC3, MC4, and Mc5 Receptors”,European Journal of Pharmacology, Section 269(1994), (1994),331-337.
Adan, Roger A., et al., “Inverse Agonism Gains Weight”,Trends in Pharmacological Sciences, vol. 24 No. 6, (Jun. 2003),315-321.
Door, Robert T., et al., “Evaluation of Melanotan-II, A Superpotent Cyclic Melanotropic Peptide in a Pilot Phase Clinical Study”,Life Science, vol. 58, No. 20 (1996),1777-1784.
Grant, G A., “Synthetic Peptides: A Users Guide”,GA Grant, editor, W.H. Freeman&Co., New York 1992, (1992),11-24.
Hadley, M E., et al., “Discovery and Development of Novel Melanogenic Drugs: Melanotan-I and -II”, Ronald. T. Borchardt, et al.editors; Intergration of Pharmaceutical Discovery and Development: Case Histories, Plenum Press, New York (1998), (1998),575-595.
Hruby, V J., et al., “Emerging Approaches in the Molecular Design of Receptor-Selective Peptide Ligands: Conformational, Topographical and Dynamic Considerations”,Biochemical Journal, (1990) 268, (1990),249-262.
Mitsunobu, Oyo, “The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis a
Burris Kevin D.
Purma Papireddy
Rajpurohit Ramesh
Shadiack Annette M.
Sharma Shubh D.
Morgan & Lewis & Bockius, LLP
Palatin Technologies Inc.
Sackey Ebenezer
Wilson James O.
LandOfFree
Melanocortin receptor-specific compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Melanocortin receptor-specific compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Melanocortin receptor-specific compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4026490